Encap Drug Delivery has collaborated with Lena Nanoceutics to develop Nano-Capsules, a new drug delivery technology that integrates Lena’s proprietary nano-particle engineering technology with Encap’s liquid-filled hard capsule technology.

Preliminary in vitro data produced using itraconazole revealed that both nano-particulate and liquid fill formulations have an improved dissolution rate compared with standard particulate drug formulations.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

When the two were combined, a greater improvement was seen.

Liquid-fill formulations can be solutions or suspensions of drug in non-aqueous liquids, found to generate increased bioavailability of the active drug.

The nano-capsule technology results in a decrease in particle size and an increased surface area, hence a faster dissolution.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact